NASDAQ:TVTX | EBITDA | Travere Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2012-03-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$11.7M
2025-12-31-$14.29M
2025-03-31-$29.87M
2024-12-31-$48.65M
2024-03-31-$129.36M
2023-12-31-$84.75M
2023-03-31-$90.75M
2022-12-31-$80.39M
2022-03-31-$59.04M
2021-12-31-$92.67M
2021-03-31-$41.48M
2020-12-31-$111.92M
2020-03-31-$9.41M
2019-12-31-$22.88M
2019-03-31-$33.33M
2018-12-31-$106,000.00
2018-03-31-$13.56M
2017-12-31-$10.71M
2017-03-31-$10.12M
2016-12-31-$14.04M
2016-03-31-$4.35M
2015-12-31-$11.23M
2015-03-31-$6.33M
2014-12-31-$16.84M
2014-03-31-$21.93M
2013-12-31-$12.21M
2013-03-31-$1.83M
2012-12-31-$13.45M
2012-03-31-$3.56M

Annual EBITDA

DateEBITDA
2025-12-31-$2.08M
2024-12-31-$280.27M
2023-12-31-$349.61M
2022-12-31-$299.09M
2021-12-31-$186.68M
2020-12-31-$151.58M
2019-12-31-$116.95M
2018-12-31-$61.37M
2017-12-31-$35.99M
2016-12-31-$42.08M
2015-12-31-$37.36M
2014-12-31-$74.41M
2013-12-31-$24.56M
2012-12-31-$30.13M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.